164 related articles for article (PubMed ID: 12646234)
1. Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.
Patra SK; Patra A; Zhao H; Carroll P; Dahiya R
Biochem Biophys Res Commun; 2003 Mar; 302(4):759-66. PubMed ID: 12646234
[TBL] [Abstract][Full Text] [Related]
2. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
[TBL] [Abstract][Full Text] [Related]
3. Active repression of methylated genes by the chromosomal protein MBD1.
Ng HH; Jeppesen P; Bird A
Mol Cell Biol; 2000 Feb; 20(4):1394-406. PubMed ID: 10648624
[TBL] [Abstract][Full Text] [Related]
4. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.
Nakao M; Matsui S; Yamamoto S; Okumura K; Shirakawa M; Fujita N
Brain Dev; 2001 Dec; 23 Suppl 1():S174-6. PubMed ID: 11738867
[TBL] [Abstract][Full Text] [Related]
5. MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland.
Billard LM; Magdinier F; Lenoir GM; Frappart L; Dante R
Oncogene; 2002 Apr; 21(17):2704-12. PubMed ID: 11965543
[TBL] [Abstract][Full Text] [Related]
6. DNA methyltransferase and demethylase in human prostate cancer.
Patra SK; Patra A; Zhao H; Dahiya R
Mol Carcinog; 2002 Mar; 33(3):163-71. PubMed ID: 11870882
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a family of mammalian methyl-CpG binding proteins.
Hendrich B; Bird A
Mol Cell Biol; 1998 Nov; 18(11):6538-47. PubMed ID: 9774669
[TBL] [Abstract][Full Text] [Related]
8. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
9. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
[TBL] [Abstract][Full Text] [Related]
10. MBD3L1 and MBD3L2, two new proteins homologous to the methyl-CpG-binding proteins MBD2 and MBD3: characterization of MBD3L1 as a testis-specific transcriptional repressor.
Jiang CL; Jin SG; Lee DH; Lan ZJ; Xu X; O'Connor TR; Szabó PE; Mann JR; Cooney AJ; Pfeifer GP
Genomics; 2002 Dec; 80(6):621-9. PubMed ID: 12504854
[TBL] [Abstract][Full Text] [Related]
11. Methyl-CpG-binding proteins. Targeting specific gene repression.
Ballestar E; Wolffe AP
Eur J Biochem; 2001 Jan; 268(1):1-6. PubMed ID: 11121095
[TBL] [Abstract][Full Text] [Related]
12. Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.
Auriol E; Billard LM; Magdinier F; Dante R
Nucleic Acids Res; 2005; 33(13):4243-54. PubMed ID: 16052033
[TBL] [Abstract][Full Text] [Related]
13. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.
Jiang CL; Jin SG; Pfeifer GP
J Biol Chem; 2004 Dec; 279(50):52456-64. PubMed ID: 15456747
[TBL] [Abstract][Full Text] [Related]
14. Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer.
Müller-Tidow C; Kügler K; Diederichs S; Klümpen S; Möller M; Vogt U; Metzger R; Schneider PM; Berdel WE; Serve H
Br J Cancer; 2001 Oct; 85(8):1168-74. PubMed ID: 11710831
[TBL] [Abstract][Full Text] [Related]
15. Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes.
Hendrich B; Abbott C; McQueen H; Chambers D; Cross S; Bird A
Mamm Genome; 1999 Sep; 10(9):906-12. PubMed ID: 10441743
[TBL] [Abstract][Full Text] [Related]
16. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription.
Yu F; Zingler N; Schumann G; Strätling WH
Nucleic Acids Res; 2001 Nov; 29(21):4493-501. PubMed ID: 11691937
[TBL] [Abstract][Full Text] [Related]
17. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
18. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
19. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase and DNA methyltransferase in human prostate cancer.
Patra SK; Patra A; Dahiya R
Biochem Biophys Res Commun; 2001 Sep; 287(3):705-13. PubMed ID: 11563853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
